ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

Congress Holds Recision Hearings

February 28, 1975

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

May 14, 2004

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002